Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC). (Q40467494)
Jump to navigation
Jump to search
scientific article published on 17 November 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC). |
scientific article published on 17 November 2016 |
Statements
1 reference
Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC). (English)
1 reference
S J L Mesnage
C Genestie
A Dunant
E Pain
F Drusch
S Gouy
E Bentivegna
C Lhomme
P Pautier
J Michels
A Le Formal
B Cheaib
17 November 2016
1 reference